Cubist Systematic Strategies’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $909K | Buy |
+63,105
| New | +$909K | ﹤0.01% | 920 |
|
|
2025
Q1 | – | Sell |
-310,369
| Closed | -$1.65M | – | 2428 |
|
|
2024
Q4 | $1.65M | Buy |
+310,369
| New | +$1.65M | 0.01% | 664 |
|
|
2024
Q2 | – | Sell |
-9,001
| Closed | -$31.3K | – | 2771 |
|
|
2024
Q1 | $31.3K | Buy |
+9,001
| New | +$31.3K | ﹤0.01% | 1966 |
|
|
2023
Q1 | – | Sell |
-11,987
| Closed | -$20.1K | – | 3345 |
|
|
2022
Q4 | $20.1K | Buy |
+11,987
| New | +$20.1K | ﹤0.01% | 3031 |
|
|
2022
Q3 | – | Sell |
-63,286
| Closed | -$106K | – | 3949 |
|
|
2022
Q2 | $106K | Buy |
63,286
+37,163
| +142% | +$62.2K | ﹤0.01% | 3420 |
|
|
2022
Q1 | $64K | Buy |
+26,123
| New | +$64K | ﹤0.01% | 3311 |
|
|
2021
Q3 | – | Sell |
-56,453
| Closed | -$557K | – | 3220 |
|
|
2021
Q2 | $557K | Buy |
56,453
+26,199
| +87% | +$258K | 0.01% | 1938 |
|
|
2021
Q1 | $283K | Sell |
30,254
-1,433
| -5% | -$13.4K | ﹤0.01% | 2291 |
|
|
2020
Q4 | $152K | Buy |
31,687
+5,521
| +21% | +$26.5K | ﹤0.01% | 2334 |
|
|
2020
Q3 | $105K | Buy |
26,166
+4,903
| +23% | +$19.7K | ﹤0.01% | 2280 |
|
|
2020
Q2 | $98K | Buy |
+21,263
| New | +$98K | ﹤0.01% | 2198 |
|